Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cabozantinib | 849217-68-1 | >98% | 500 MG
SDP

Supplier:  Medchemexpress LLC HY13016500MG

Encompass_Preferred

Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET. It displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3. Cabozantinib shows antiangiogenic activity, disrupts tumor vasculature, and promotes tumor and endothelial cell apoptosis.

  • Potent and orally active inhibitor of VEGFR2 and MET
  • Displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3
  • Shows antiangiogenic activity
  • Disrupts tumor vasculature
  • Promotes tumor and endothelial cell apoptosis

Catalog No. 50-003-40995


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.